ReP USP - Resultado da busca

Artigo de periodico
Measuring disease damage and its severity in childhood-onset systemic lupus erythematosus (2018)
Holland, Michael J; Beresford, Michael W; Feldman, Brian M; Huggins, Jennifer; Norambuena, Ximena; Silva, Clovis A; Susic, Gordana; Sztajnbok, Flavio; Uziel, Yosef; Appenzeller, Simone
Source: Arthritis care & research. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, INFÂNCIA, ÍNDICE DE GRAVIDADE DA DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOLLAND, Michael J et al. Measuring disease damage and its severity in childhood-onset systemic lupus erythematosus. Arthritis care & research, v. 70, n. 11, p. 1621-1629, 2018Tradução . . Disponível em: https://doi.org/10.1002/acr.23531. Acesso em: 06 nov. 2024.
APA
Holland, M. J., Beresford, M. W., Feldman, B. M., Huggins, J., Norambuena, X., Silva, C. A., et al. (2018). Measuring disease damage and its severity in childhood-onset systemic lupus erythematosus. Arthritis care & research, 70( 11), 1621-1629. doi:10.1002/acr.23531
NLM
Holland MJ, Beresford MW, Feldman BM, Huggins J, Norambuena X, Silva CA, Susic G, Sztajnbok F, Uziel Y, Appenzeller S. Measuring disease damage and its severity in childhood-onset systemic lupus erythematosus [Internet]. Arthritis care & research. 2018 ; 70( 11): 1621-1629.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/acr.23531
Vancouver
Holland MJ, Beresford MW, Feldman BM, Huggins J, Norambuena X, Silva CA, Susic G, Sztajnbok F, Uziel Y, Appenzeller S. Measuring disease damage and its severity in childhood-onset systemic lupus erythematosus [Internet]. Arthritis care & research. 2018 ; 70( 11): 1621-1629.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/acr.23531
Artigo de periodico
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration (2014)
Moorthy, Lakshmi Nandini; Roy, Elizabeth; Kurra, Vamsi; Peterson, Margaret G. E.; Hassett, Afton L.; Lehman, Thomas J. A.; Scott, Christiaan; El-Ghoneimy, Dalia; Saad, Shereen; El Feky, Reem; Al-Mayouf, Sulaiman; Dolezalova, Pavla; Malcova, Hana; Herlin, Troels; Nielsen, Susan; Wulffraat, Nico; van Royen, Annet; Marks, Stephen D.; Belot, Alexandre; Brunner, Jurgen; Huemer, Christian; Foeldvari, Ivan; Horneff, Gerd; Saurenman, Traudel; Schroeder, Silke; ; Pratsidou-Gertsi, Polyxeni; Trachana, Maria; Uziel, Yosef; Aggarwal, Amita; Constantin, Tamas; Cimaz, Rolando; Giani, Theresa; Cantarini, Luca; Falcini, Fernanda; Manzoni, Silvia Magni; Ravelli, Angelo; Rigante, Donato; Zulian, Fracnceso; Miyamae, Takako; Yokota, Shumpei; Sato, Juliana; Magalhaes, Claudia S.; Len, Claudio A.; Appenzeller, Simone; Knupp, Sheila Oliveira; Rodrigues, Marta Cristine; Sztajnbok, Flavio; Almeida, Rozana Gasparello de; Jesus, Adriana Almeida de; Campos, Lucia Maria de Arruda; Silva, Clovis; Lazar, Calin; Susic, Gordana; Avcin, Tadej; Cuttica, Ruben; Burgos-Vargas, Ruben; Faugier, Enrique; Anton, Jordi; Modesto, Consuelo; Vazquez, Liza; Barillas, Lilliana; Barinstein, Laura; Sterba, Gary; Maldonado, Irama; Ozen, Seza; Kasapcopur, Ozgur; Demirkaya, Erkan; Benseler, Susa
Source: Pediatric Rheumatology. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, QUALIDADE DE VIDA, FÁRMACOS ANTIRREUMÁTICOS, DOENÇAS REUMÁTICAS (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOORTHY, Lakshmi Nandini et al. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration. Pediatric Rheumatology, v. 12, n. 1, p. 6 , 2014Tradução . . Disponível em: https://doi.org/10.1186/1546-0096-12-49. Acesso em: 06 nov. 2024.
APA
Moorthy, L. N., Roy, E., Kurra, V., Peterson, M. G. E., Hassett, A. L., Lehman, T. J. A., et al. (2014). Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration. Pediatric Rheumatology, 12( 1), 6 . doi:10.1186/1546-0096-12-49
NLM
Moorthy LN, Roy E, Kurra V, Peterson MGE, Hassett AL, Lehman TJA, Scott C, El-Ghoneimy D, Saad S, El Feky R, Al-Mayouf S, Dolezalova P, Malcova H, Herlin T, Nielsen S, Wulffraat N, van Royen A, Marks SD, Belot A, Brunner J, Huemer C, Foeldvari I, Horneff G, Saurenman T, Schroeder S, , Pratsidou-Gertsi P, Trachana M, Uziel Y, Aggarwal A, Constantin T, Cimaz R, Giani T, Cantarini L, Falcini F, Manzoni SM, Ravelli A, Rigante D, Zulian F, Miyamae T, Yokota S, Sato J, Magalhaes CS, Len CA, Appenzeller S, Knupp SO, Rodrigues MC, Sztajnbok F, Almeida RG de, Jesus AA de, Campos LM de A, Silva C, Lazar C, Susic G, Avcin T, Cuttica R, Burgos-Vargas R, Faugier E, Anton J, Modesto C, Vazquez L, Barillas L, Barinstein L, Sterba G, Maldonado I, Ozen S, Kasapcopur O, Demirkaya E, Benseler S. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration [Internet]. Pediatric Rheumatology. 2014 ; 12( 1): 6 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/1546-0096-12-49
Vancouver
Moorthy LN, Roy E, Kurra V, Peterson MGE, Hassett AL, Lehman TJA, Scott C, El-Ghoneimy D, Saad S, El Feky R, Al-Mayouf S, Dolezalova P, Malcova H, Herlin T, Nielsen S, Wulffraat N, van Royen A, Marks SD, Belot A, Brunner J, Huemer C, Foeldvari I, Horneff G, Saurenman T, Schroeder S, , Pratsidou-Gertsi P, Trachana M, Uziel Y, Aggarwal A, Constantin T, Cimaz R, Giani T, Cantarini L, Falcini F, Manzoni SM, Ravelli A, Rigante D, Zulian F, Miyamae T, Yokota S, Sato J, Magalhaes CS, Len CA, Appenzeller S, Knupp SO, Rodrigues MC, Sztajnbok F, Almeida RG de, Jesus AA de, Campos LM de A, Silva C, Lazar C, Susic G, Avcin T, Cuttica R, Burgos-Vargas R, Faugier E, Anton J, Modesto C, Vazquez L, Barillas L, Barinstein L, Sterba G, Maldonado I, Ozen S, Kasapcopur O, Demirkaya E, Benseler S. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration [Internet]. Pediatric Rheumatology. 2014 ; 12( 1): 6 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/1546-0096-12-49
Artigo de periodico
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial (2010)
Foell, Dirk; Wulffraat, Nico; Garay, Stella; Vojinovic, Jelena; Norambuena, Ximena; Gamir, María Luz; Consuegra, Julia García; Lepore, Loredana; Susic, Gordana; Corona, Fabrizia; Dolezalova, Pavla; Pistorio, Angela; Martini, Alberto; Ruperto, Nicolino; Roth, johannes; Wedderburn, Lucy R.; Wittkowski, Helmut; Frosch, Michael; Gerf, Joachim; Stanevicha, Valda; Mihaylova, Dimitrina; Ferriani, Virgínia Paes Leme; Tsakalidou, Florence Kanakoudi; Foeldvari, Ivan; Cuttica, Ruben; Gonzalez, Benito; Ravelli, Angelo; khubchandani, Raju; Oliveira, Sheila; Armbrust, Wineke
Source: JAMA: The Journal of the American Medical Association. Unidade: FMRP
Subjects: ARTRITE REUMATOIDE JUVENIL, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOELL, Dirk et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association, v. 303, n. 13, p. 1266-1273, 2010Tradução . . Acesso em: 06 nov. 2024.
APA
Foell, D., Wulffraat, N., Garay, S., Vojinovic, J., Norambuena, X., Gamir, M. L., et al. (2010). Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association, 303( 13), 1266-1273.
NLM
Foell D, Wulffraat N, Garay S, Vojinovic J, Norambuena X, Gamir ML, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Pistorio A, Martini A, Ruperto N, Roth johannes, Wedderburn LR, Wittkowski H, Frosch M, Gerf J, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Ravelli A, khubchandani R, Oliveira S, Armbrust W. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association. 2010 ; 303( 13): 1266-1273.[citado 2024 nov. 06 ]
Vancouver
Foell D, Wulffraat N, Garay S, Vojinovic J, Norambuena X, Gamir ML, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Pistorio A, Martini A, Ruperto N, Roth johannes, Wedderburn LR, Wittkowski H, Frosch M, Gerf J, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Ravelli A, khubchandani R, Oliveira S, Armbrust W. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association. 2010 ; 303( 13): 1266-1273.[citado 2024 nov. 06 ]

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Indexado em